Treatment decision - Jeg har Kræft

Rectal cancer – Block pathways. Metabolic approaches to cancer treatment. Cancer in the rectum.

June 6, 2026
Anal cancer – Block pathways. Metabolic approaches to cancer treatment. Esophageal cancer. Anal cancer. Blocking cancer at the anus.

June 6, 2026
Stomach cancer – Metabolic approaches to cancer treatment. Gastric cancer. Blocking pathways in stomach cancer. Ventricular cancer. Gastric cancer. Adenocarcinoma. Intestinal type. Diffuse type. Signet ring cell carcinoma. HER2-positive. EBV-positive. GEJ cancer. GIST. Gastrointestinal stromal tumor. Metastatic stomach cancer.

June 6, 2026
Mesothelioma – Metabolic approaches to cancer treatment. Cancer of the pleura. Block mesothelioma’s pathways.

May 26, 2026
Lung cancer – Metabolic approaches to cancer treatment. Cancer of the lungs.

May 26, 2026
Gallbladder and bile duct cancer. Blocking pathways in gallbladder cancer. Gallbladder cancer. Cholangiocarcinoma. Intrahepatic. Extrahepatic. Klatskin tumor. Adenocarcinoma. IDH1 mutation. FGFR2 fusion. HER2-positive. Adenosquamous carcinoma. Metastatic bile duct cancer.

May 26, 2026
Liver cancer – Metabolic approaches to cancer treatment for cancer of the liver. Cancer hepaticus. Blocking pathways in liver cancer.

May 26, 2026
Bone Cancer – Metabolic approaches to cancer treatment. Cancer in the bones. Bone metastases

May 25, 2026
Skin Cancer and Melanoma – Metabolic approaches to cancer treatment. Dermatological cancer. Basal cell carcinoma (BCC). Squamous cell carcinoma (SCC). Actinic keratosis. Melanoma. Melanoma (BRAF-mutated). Melanoma (BRAF-negative / wildtype). Merkel cell carcinoma (MCC). Metastatic skin cancer.

May 25, 2026
Eye Cancer. Metabolic blockade. Pathway blockade. Uveal Melanom. Melanoma of the eye. Retinoblastoma. Conjunctival Melanoma. Lacrimal gland cancer. Adenoid Cystic Carcinoma. Squamous cell carcinoma of the eye.

May 25, 2026